Bronchiolitis. Acute bronchiolitis due to respiratory syncytial virus
Conditions
Interventions
Intervention 1: In the intervention group, alongside routine treatments, furosemide ampoules manufactured by Abu Raihan Pharmaceutical Company will be administered in the form of nebulizer twice dail
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: Parental consent for the child's participation in the study is required. The child should not have been previously hospitalized for the current illness at any hospital or treatment center, and must not have any underlying conditions that could affect the assessment of bronchiolitis severity.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bronchiolitis severity. Timepoint: At the beginning of the study and three days after the intervention. Method of measurement: Wang scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of days in the hospita. Timepoint: At the beginning of the study and three days after the intervention. Method of measurement: According to the hospital records.;Oxygen saturation percentage. Timepoint: At the beginning of the study and three days after the intervention. Method of measurement: Pulse oximeter device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArdeshir Rahimi
Tehran University of Medical Sciences
Outcome results
None listed